PTPRC and hydrops fetalis: Thus, significantly reduced levels of PS+-EVs carrying CD45+ (LEVs; p = 0.007), CD11b+ (LEVs; p < 0.001), CD14+ (mEVs; p = 0.036), and CD15+ (nEVs; p = 0.001) markers were observed in the non-HF subjects in relation with the patients with cHF.